Haemate P

In the US, Haemate P is a member of the drug class miscellaneous coagulation modifiers and is used to treat Hemophilia A and von Willebrand's Disease.

UK matches:

• Haemate P 500 and 1000 IU
• Haemate P 500 and 1000 IU (SPC)

Ingredient matches for Haemate P

Coagulation Factor VIII , Human (rDNA)

Coagulation Factor VIII , Human (rDNA) Octocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of Haemate P in the following countries:

• Belgium

Coagulation Factor VIII, Human

Coagulation Factor VIII, Human is reported as an ingredient of Haemate P in the following countries:

• Austria


• Germany


• Greece


• Hong Kong


• Italy


• Netherlands


• Poland


• Slovakia


• Spain


• Switzerland


• Taiwan


• Turkey


• United Kingdom

Von Willebrand Factor, Human

Von Willebrand Factor, Human is reported as an ingredient of Haemate P in the following countries:

• Belgium


• Germany


• Greece


• Netherlands


• Spain


• Switzerland


• United Kingdom

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.